SCHEMBL31622708

SCHEMBL31622708

O=C(c1ccc(-c2cc(Cl)c3occc3c2)cc1)N1CCC(F)(F)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 1/20 0.41
▸ PDE4A P27815 1/20 0.41
▸ PDE1A P54750 1/20 0.41
▸ PDE1B Q01064 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ PDE7A Q13946 1/20 0.41
▸ PDE1C Q14123 1/20 0.41
▸ PDE3A Q14432 1/20 0.41
▸ PDE7B Q9NP56 1/20 0.41
▸ PKLR P30613 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ FASN P49327 9/20 0.40
▸ HPGD P15428 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ PAK4 O96013 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31622671 0.89 CCNC (0.39) PDE5APDE4APDE1APDE1BPDE4B
SCHEMBL31622622 0.86 HPGD (0.52) PDE5APDE4APDE1APDE1BPDE4B
SCHEMBL31622713 0.86 GABRA5 (0.45) PKLRHPGDPAK4LRRK2
SCHEMBL31622651 0.85 HPGD (0.45) ALDH1A1LMNATSHRNPSR1HPGD
SCHEMBL31622701 0.85 PHGDH (0.53) ALDH1A1HPGDMAPK1JAK2MKNK1
SCHEMBL31622669 0.84 L3MBTL1 (0.53) ALDH1A1LMNATSHRNPSR1HPGD
SCHEMBL31622694 0.84 POLB (0.56) PDE5APDE4APDE1APDE1BPDE4B
SCHEMBL28217078 0.84 PAK4 (0.51) ALDH1A1LMNATSHRNPSR1FASN
SCHEMBL28216598 0.83 PAK4 (0.45) ALDH1A1LMNATSHRNPSR1FASN
SCHEMBL31622580 0.82 PDE5A (0.46) PDE5APDE4APDE1APDE1BPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260085064-A1 SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF KARYOPHARM THERAPEUTICS INC (US) 2026-03-26 — — US disclosed
US-12331040-B2 Substituted benzofuranyl and benzoxazolyl compounds and uses thereof Karyopharm Therapeutics Inc. (US) 2025-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12331040-B2 Substituted benzofuranyl and benzoxazolyl compounds and uses thereof BCL6, MALT1, BTK PDE5A 3520/4885PDE4A 4296/4885PDE1A 4671/4885
US-20260085064-A1 SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF BCL6, MALT1, BCL6B PDE5A 2783/4885PDE4A 3798/4885PDE1A 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback